| PERIOD ENDING | 31-Oct-09 | 31-Jul-09 | 30-Apr-09 | 31-Jan-09 | | Total Revenue | 99,411,000 | 100,910,000 | 94,242,000 | 109,116,000 | | Cost of Revenue | 73,805,000 | 75,153,000 | 70,388,000 | 82,601,000 | | | Gross Profit | 25,606,000 | 25,757,000 | 23,854,000 | 26,515,000 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 20,013,000 | 19,875,000 | 18,637,000 | 20,138,000 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 5,593,000 | 5,882,000 | 5,217,000 | 6,377,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 35,000 | 42,000 | 51,000 | 68,000 | | Earnings Before Interest And Taxes | 5,628,000 | 5,924,000 | 5,268,000 | 6,445,000 | | Interest Expense | 510,000 | 515,000 | 518,000 | 560,000 | | Income Before Tax | 5,118,000 | 5,409,000 | 4,750,000 | 5,885,000 | | Income Tax Expense | 1,758,000 | 1,853,000 | 1,603,000 | 1,959,000 | | Minority Interest | (338,000) | 117,000 | (117,000) | (134,000) | | | | Net Income From Continuing Ops | 3,360,000 | 3,673,000 | 3,030,000 | 3,792,000 | | | Non-recurring Events | | Discontinued Operations | (7,000) | (7,000) | (8,000) |
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 3,015,000 | 3,666,000 | 3,022,000 | 3,792,000 | | Preferred Stock And Other Adjustments | 224,000 | (224,000) |
-
|
-
| | | Net Income Applicable To Common Shares | $3,239,000 | $3,442,000 | $3,022,000 | $3,792,000 |
|
0.20% Nasdaq 
Income Statement
